C.E. FARMA
ActiveSummary
C.E. FARMA has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €68,611. Equity remains stable across the filed financial years (±1.1% per year). Its solvency ranks better than 92% of 12,519 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
29-07
Gazette deed
Resignation: BV ALEXO (director)Permanent representatives: Olivier Delaere, Koen Straetmans and Tom Goderis · Appointment: BV KST Pharma (director) · Reappointment: BV SODIAP (managing director)8 facts ▸
- General meeting, 19-05-2026
- Director resignation, BV ALEXO (director)
- Permanent representative, Olivier Delaere
- Director appointment, BV KST Pharma (director)
- Permanent representative, Koen Straetmans
- Board meeting, 19-05-2026
- Director reappointment, BV SODIAP (managing director)
- Permanent representative, Tom Goderis
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.